Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This prospective pilot study is designed to evaluate the accuracy of contrast-enhanced
ultrasound when used to evaluate renal lesions in two different populations; patients with
known renal tumors (Cohort 1) and patients with a risk factor for renal malignancy in whom
their screening ultrasound shows an indeterminate or possibly malignant renal mass (Cohort
2).